SA
HCA icon

Strategic Advocates’s HCA Healthcare HCA Stock Holding History

Strategic Advocates’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1K Buy
26
+17
+189% +$7.19K 0.04% 160
2026
Q1 		$4.26K Sell
9
-161
-95% -$81K 0.02% 193
2025
Q4 		$80.6K Hold
170
– – 0.02% 165
2025
Q3 		$72.6K Buy
+170
New +$65.9K 0.02% 179
2024
Q1 		– Sell
-909
Closed -$246K – 147
2023
Q4 		$246K Sell
909
-201
-18% -$49.7K 0.1% 127
2023
Q3 		$273K Buy
+1,110
New +$304K 0.13% 112

Other funds holding HCA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Strategic Advocates's HCA Position: Q2 2026 in Review

Strategic Advocates increased its HCA Healthcare (HCA) stake by 189% in Q2 2026, buying an estimated $7.19K and bringing the position to 26 shares worth $10.1K. The position accounts for 0.04% of the portfolio, ranked #160.

Strategic Advocates first reported a position in HCA in Q3 2023 and has held it in 6 quarters since. The position peaked at $273K in Q3 2023. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Strategic Advocates held 26 shares of HCA Healthcare worth $10.1K as of Q2 2026.
  • Strategic Advocates bought 17 HCA Healthcare shares in Q2 2026, an estimated $7.19K.
  • HCA Healthcare made up 0.04% of Strategic Advocates's portfolio in Q2 2026, its #160 holding.
  • Strategic Advocates first reported a position in HCA Healthcare in Q3 2023 and has held it in 6 quarters since.
  • Strategic Advocates's HCA Healthcare position peaked at $273K in Q3 2023.
  • 1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Strategic Advocates's 13F filing for Q2 2026, filed 13 Aug 2026.